Sydney Marie Moyer, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tumor Suppressor Protein p53 | 4 | 2024 | 2944 | 0.570 |
Why?
|
| Organ Specificity | 1 | 2020 | 2008 | 0.520 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 2177 | 0.360 |
Why?
|
| Vaccinia | 1 | 2022 | 76 | 0.210 |
Why?
|
| Endogenous Retroviruses | 1 | 2020 | 112 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2020 | 381 | 0.150 |
Why?
|
| Retinoids | 1 | 2018 | 101 | 0.150 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2020 | 893 | 0.150 |
Why?
|
| Neuroblastoma | 1 | 2022 | 1226 | 0.120 |
Why?
|
| Neuroendocrine Tumors | 1 | 2020 | 594 | 0.120 |
Why?
|
| Intestine, Small | 1 | 2020 | 1240 | 0.120 |
Why?
|
| Pancreas | 1 | 2020 | 1686 | 0.110 |
Why?
|
| Tamoxifen | 1 | 2018 | 981 | 0.110 |
Why?
|
| Neoplasms, Experimental | 1 | 2018 | 1272 | 0.110 |
Why?
|
| Adenoma | 1 | 2023 | 2173 | 0.100 |
Why?
|
| Carcinoma | 1 | 2023 | 2375 | 0.100 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2023 | 2428 | 0.080 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 9731 | 0.080 |
Why?
|
| Mice | 7 | 2024 | 81154 | 0.080 |
Why?
|
| Glioma | 1 | 2022 | 3401 | 0.080 |
Why?
|
| Adenocarcinoma | 1 | 2024 | 6363 | 0.070 |
Why?
|
| Colorectal Neoplasms | 1 | 2023 | 6773 | 0.060 |
Why?
|
| Pancreatic Neoplasms | 1 | 2020 | 5264 | 0.050 |
Why?
|
| Animals | 7 | 2024 | 168660 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 8430 | 0.050 |
Why?
|
| Mutation, Missense | 2 | 2023 | 2566 | 0.050 |
Why?
|
| Tumor Microenvironment | 2 | 2024 | 3583 | 0.050 |
Why?
|
| Ubiquitins | 1 | 2023 | 384 | 0.050 |
Why?
|
| Genes, p53 | 1 | 2023 | 755 | 0.050 |
Why?
|
| Vaccinia virus | 1 | 2022 | 349 | 0.050 |
Why?
|
| Co-Repressor Proteins | 1 | 2020 | 194 | 0.040 |
Why?
|
| Hyperplasia | 1 | 2023 | 1185 | 0.040 |
Why?
|
| Nervous System | 1 | 2022 | 554 | 0.040 |
Why?
|
| Ubiquitination | 1 | 2023 | 1011 | 0.040 |
Why?
|
| Molecular Chaperones | 1 | 2020 | 742 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2018 | 1826 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2023 | 1940 | 0.030 |
Why?
|
| Intestines | 1 | 2023 | 1923 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2018 | 1794 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2022 | 2914 | 0.030 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2018 | 1523 | 0.020 |
Why?
|
| Cell Line | 1 | 2023 | 15993 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2024 | 16674 | 0.020 |
Why?
|
| Genomics | 1 | 2023 | 5714 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 4422 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2023 | 11478 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2020 | 5854 | 0.020 |
Why?
|
| Inflammation | 1 | 2023 | 10629 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2018 | 5170 | 0.010 |
Why?
|
| Male | 1 | 2020 | 349776 | 0.010 |
Why?
|
| Female | 1 | 2020 | 380020 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2023 | 23398 | 0.010 |
Why?
|
| Mutation | 1 | 2023 | 29777 | 0.010 |
Why?
|
| Humans | 4 | 2024 | 743811 | 0.010 |
Why?
|
| Child | 1 | 2022 | 77637 | 0.010 |
Why?
|